NL
DE
We need to work towards a future where organ on a chip technology is more accurate in mimicking the human body than any animal could ever be.Because over 110 million animals are used in experiments to develop new medicine. Organ by organ we will need to develop better alternatives than the experiments that are done on animals now.
Our spin-off company Cell4Pharma focuses on developing a model that is more accurate in mimicking the human kidney than any other animal experiment on the market.
Grab this opportunity to be part of their mission and become an investor.
Check out their crowdfunding page on Symbid here: http://www.symbid.nl/projects/427
Related news items
Third Radboudumc Investment Day again well-attended
16 October 2023On October 12, the Radboudumc Investment Day took place for the third time. Scientists, entrepreneurs and investors from the life sciences & health sector came together in the Radboudumc Experience Center to exchange knowledge, network and talk about new collaborations.
read more
Soteria Medical BV announces collaboration with ALLEAD
27 July 2023Radboudumc spin-off Soteria Medical BV announces collaboration with ALLEAD.
read more
Take Off 2 funding from NWO for Predica Diagnostics
30 June 2023Predica Diagnostics just secured the Take Off 2 funding to accelerate development of their cervical (pre)cancer prediction test.
read more
Boosting the startup ecosystem in Nijmegen!
22 June 2023TechleapNL, Radboud university, Radboudumc and the municipality of Nijmegen hosted a successful event where innovative health and hightech startups shared their view on the challenges and opportunities for the local startup ecosystem.
read more
Meet Healthy Ideas, Healthy Returns
2 June 2023Do you have a golden idea to improve healthcare, but not the resources to realize it? Discover Healthy Ideas, Healthy Returns: a Benelux-wide public-private network offering opportunities for healthcare investments and propositions, among other things.
read more
Cell4Pharma successfully closed a major funding round
25 May 2023Radboudumc spin-off Cell4Pharma is pleased to announced it has successfully closed a major funding round, marking a significant milestone in their journey towards developing ciPTEC as the leading platform to study human renal biological interaction during the preclinical stages of drug development
read more